Targeting Nonpulmonary Vein Sources in Persistent Atrial Fibrillation Identified by Noncontact Charge Density Mapping: UNCOVER AF Trial

Stephan Willems, Atul Verma*, Timothy R. Betts, Steven Murray, Petr Neuzil, Hueseyin Ince, Daniel Steven, Arian Sultan, Patrick M. Heck, Mark C. Hall, Claudio Tondo, Laurent Pison, Tom Wong, Lucas V. Boersma, Christian Meyer, Andrew Grace

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

52 Citations (Web of Science)

Abstract

Background Identification and elimination of nonpulmonary vein targets may improve clinical outcomes in patients with persistent atrial fibrillation (AF). We report on the use of a novel, noncontact imaging and mapping system that uses ultrasound to reconstruct atrial chamber anatomy and measures timing and density of dipolar, ionic activation (ie, charge density) across the myocardium to guide ablation of atrial arrhythmias. Methods The prospective, nonrandomized UNCOVER AF trial (Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Rhythms in Atrial Fibrillation) was conducted at 13 centers across Europe and Canada. Patients with persistent AF (>7 days, 30 seconds at 12 months for a single procedure with a secondary outcome being acute procedural efficacy. The primary safety outcome was freedom from device/procedure-related major adverse events. Results Between October 2016 and April 2017, 129 patients were enrolled, and 127 underwent mapping and catheter ablation. Acute procedural efficacy was demonstrated in 125 patients (98%). At 12 months, single procedure freedom from AF on or off antiarrhythmic drugs was 72.5% (95% CI, 63.9%-80.3%). After 1 or 2 procedures, freedom from AF was 93.2% (95% CI, 87.1%-97.0%). A total of 29 (23%) retreatments because of arrhythmia recurrence were performed with average time from index procedure to first retreatment being 7 months. The primary safety outcome was 98% with no device-related major adverse events reported. Conclusions This novel ultrasound imaging and charge density mapping system safely guided ablation of nonpulmonary vein targets in persistent AF patients with 73% single procedure and 93% second procedure freedom from AF at 12 months.

Original languageEnglish
Article number007233
Pages (from-to)1-12
Number of pages12
JournalCirculation-Arrhythmia and Electrophysiology
Volume12
Issue number7
DOIs
Publication statusPublished - Jul 2019

Keywords

  • CATHETER ABLATION
  • CRYOBALLOON
  • Canada
  • Europe
  • MANAGEMENT
  • atrial fibrillation
  • heart atria
  • humans
  • HEART-FAILURE

Cite this